|
TCMBANKGE000047 |
AKT1 |
AKT; CWS6; PKB; PKB-ALPHA; PRKBA; RAC; RAC-ALPHA |
AKT serine/threonine kinase 1 |
|
TCMBANKGE000139 |
POR |
CPR; CYPOR; P450R |
cytochrome p450 oxidoreductase |
|
TCMBANKGE000163 |
TNFRSF1B |
CD120b; TBPII; TNF-R-II; TNF-R75; TNFBR; TNFR1B; TNFR2; TNFR80; p75; p75TNFR |
TNF receptor superfamily member 1B |
|
TCMBANKGE000171 |
DNMT1 |
ADCADN; AIM; CXXC9; DNMT; HSN1E; MCMT; m.HsaI |
DNA methyltransferase 1 |
|
TCMBANKGE000199 |
ICAM1 |
BB2; CD54; P3.58 |
intercellular adhesion molecule 1 |
|
TCMBANKGE000205 |
NOS2 |
HEP-NOS; INOS; NOS; NOS2A |
nitric oxide synthase 2 |
|
TCMBANKGE000230 |
ADIPOQ |
ACDC; ACRP30; ADIPQTL1; ADPN; APM-1; APM1; GBP28 |
adiponectin, C1Q and collagen domain containing |
|
TCMBANKGE000241 |
CASP8 |
ALPS2B; CAP4; Casp-8; FLICE; MACH; MCH5 |
caspase 8 |
|
TCMBANKGE000245 |
CYBB |
AMCBX2; CGD; GP91-1; GP91-PHOX; GP91PHOX; IMD34; NOX2; p91-PHOX |
cytochrome b-245 beta chain |
|
TCMBANKGE000260 |
APOB |
FCHL2; FLDB; LDLCQ4; apoB-100; apoB-48 |
apolipoprotein B |
|
TCMBANKGE000264 |
ABCB1 |
ABC20; CD243; CLCS; GP170; MDR1; P-GP; PGY1 |
ATP binding cassette subfamily B member 1 |
|
TCMBANKGE000271 |
APOE |
AD2; APO-E; ApoE4; LDLCQ5; LPG |
apolipoprotein E |
|
TCMBANKGE000276 |
NOS1 |
IHPS1; N-NOS; NC-NOS; NOS; bNOS; nNOS |
nitric oxide synthase 1 |
|
TCMBANKGE000294 |
CDKN1A |
CAP20; CDKN1; CIP1; MDA-6; P21; SDI1; WAF1; p21CIP1 |
cyclin dependent kinase inhibitor 1A |
|
TCMBANKGE000299 |
HMGCR |
LDLCQ3 |
3-hydroxy-3-methylglutaryl-CoA reductase |
|
TCMBANKGE000321 |
NOX4 |
KOX; KOX-1; RENOX |
NADPH oxidase 4 |
|
TCMBANKGE000330 |
HMOX1 |
HMOX1D; HO-1; HSP32; bK286B10 |
heme oxygenase 1 |
|
TCMBANKGE000381 |
RHOB |
ARH6; ARHB; MST081; MSTP081; RHOH6 |
ras homolog family member B |
|
TCMBANKGE000445 |
CD44 |
CDW44; CSPG8; ECMR-III; HCELL; HUTCH-I; IN; LHR; MC56; MDU2; MDU3; MIC4; Pgp1 |
CD44 molecule (Indian blood group) |
|
TCMBANKGE000473 |
TRPC6 |
FSGS2; TRP6 |
transient receptor potential cation channel subfamily C member 6 |
|
TCMBANKGE000533 |
SLCO1B1 |
HBLRR; LST-1; LST1; OATP-C; OATP1B1; OATP2; OATPC; SLC21A6 |
solute carrier organic anion transporter family member 1B1 |
|
TCMBANKGE000566 |
HMGA1 |
HMG-R; HMGA1A; HMGIY |
high mobility group AT-hook 1 |
|
TCMBANKGE000585 |
BCL2L11 |
BAM; BIM; BOD |
BCL2 like 11 |
|
TCMBANKGE000611 |
CSF2 |
CSF; GMCSF |
colony stimulating factor 2 |
|
TCMBANKGE000639 |
HRAS |
C-BAS/HAS; C-H-RAS; C-HA-RAS1; CTLO; H-RASIDX; HAMSV; HRAS1; RASH1; p21ras |
HRas proto-oncogene, GTPase |
|
TCMBANKGE000661 |
HDAC2 |
HD2; KDAC2; RPD3; YAF1 |
histone deacetylase 2 |
|
TCMBANKGE000665 |
CASP6 |
MCH2 |
caspase 6 |
|
TCMBANKGE000692 |
PNPLA2 |
1110001C14Rik; ATGL; FP17548; PEDF-R; TTS-2.2; TTS2; iPLA2zeta |
patatin like phospholipase domain containing 2 |
|
TCMBANKGE000739 |
NOX5 |
- |
NADPH oxidase 5 |
|
TCMBANKGE000740 |
NOX1 |
GP91-2; MOX1; NOH-1; NOH1 |
NADPH oxidase 1 |
|
TCMBANKGE000781 |
LDLR |
FH; FHC; FHCL1; LDLCQ2 |
low density lipoprotein receptor |
|
TCMBANKGE000825 |
CDKN1B |
CDKN4; KIP1; MEN1B; MEN4; P27KIP1 |
cyclin dependent kinase inhibitor 1B |
|
TCMBANKGE000874 |
AURKB |
AIK2; AIM-1; AIM1; ARK-2; ARK2; AurB; IPL1; PPP1R48; STK-1; STK12; STK5; aurkb-sv1; aurkb-sv2 |
aurora kinase B |
|
TCMBANKGE000881 |
PLAT |
T-PA; TPA |
plasminogen activator, tissue type |
|
TCMBANKGE000921 |
CCNB1 |
CCNB |
cyclin B1 |
|
TCMBANKGE000938 |
CDK2 |
CDKN2; p33(CDK2) |
cyclin dependent kinase 2 |
|
TCMBANKGE000954 |
ABCB11 |
ABC16; BRIC2; BSEP; PFIC-2; PFIC2; PGY4; SPGP |
ATP binding cassette subfamily B member 11 |
|
TCMBANKGE000968 |
CYCS |
CYC; HCS; THC4 |
cytochrome c, somatic |
|
TCMBANKGE000970 |
FASN |
FAS; OA-519; SDR27X1 |
fatty acid synthase |
|
TCMBANKGE000979 |
KDR |
CD309; FLK1; VEGFR; VEGFR2 |
kinase insert domain receptor |
|
TCMBANKGE000990 |
EGFR |
ERBB; ERBB1; HER1; NISBD2; PIG61; mENA |
epidermal growth factor receptor |
|
TCMBANKGE001008 |
CYP3A4 |
CP33; CP34; CYP3A; CYP3A3; CYPIIIA3; CYPIIIA4; HLP; NF-25; P450C3; P450PCN1 |
cytochrome P450 family 3 subfamily A member 4 |
|
TCMBANKGE001013 |
BIRC5 |
API4; EPR-1 |
baculoviral IAP repeat containing 5 |
|
TCMBANKGE001015 |
RAC1 |
MIG5; MRD48; Rac-1; TC-25; p21-Rac1 |
Rac family small GTPase 1 |
|
TCMBANKGE001037 |
MMP2 |
CLG4; CLG4A; MMP-2; MMP-II; MONA; TBE-1 |
matrix metallopeptidase 2 |
|
TCMBANKGE001045 |
CCND1 |
BCL1; D11S287E; PRAD1; U21B31 |
cyclin D1 |
|
TCMBANKGE001054 |
ABCA1 |
ABC-1; ABC1; CERP; HDLCQTL13; HDLDT1; HPALP1; TGD |
ATP binding cassette subfamily A member 1 |
|
TCMBANKGE001073 |
PTGS2 |
COX-2; COX2; GRIPGHS; PGG/HS; PGHS-2; PHS-2; hCox-2 |
prostaglandin-endoperoxide synthase 2 |
|
TCMBANKGE001079 |
CYP1A1 |
AHH; AHRR; CP11; CYP1; CYPIA1; P1-450; P450-C; P450DX |
cytochrome P450 family 1 subfamily A member 1 |
|
TCMBANKGE001085 |
MAPK8 |
JNK; JNK-46; JNK1; JNK1A2; JNK21B1/2; PRKM8; SAPK1; SAPK1c |
mitogen-activated protein kinase 8 |
|
TCMBANKGE001097 |
HIF1A |
HIF-1-alpha; HIF-1A; HIF-1alpha; HIF1; HIF1-ALPHA; MOP1; PASD8; bHLHe78 |
hypoxia inducible factor 1 subunit alpha |
|
TCMBANKGE001107 |
NOS3 |
ECNOS; eNOS |
nitric oxide synthase 3 |
|
TCMBANKGE001108 |
BMP2 |
BDA2; BMP2A; SSFSC |
bone morphogenetic protein 2 |
|
TCMBANKGE001113 |
ACTA2 |
ACTSA |
actin alpha 2, smooth muscle |
|
TCMBANKGE001116 |
CYP7A1 |
CP7A; CYP7; CYPVII |
cytochrome P450 family 7 subfamily A member 1 |
|
TCMBANKGE001117 |
PTEN |
10q23del; BZS; CWS1; DEC; GLM2; MHAM; MMAC1; PTEN1; PTENbeta; TEP1 |
phosphatase and tensin homolog |
|
TCMBANKGE001118 |
MMP9 |
CLG4B; GELB; MANDP2; MMP-9 |
matrix metallopeptidase 9 |
|
TCMBANKGE001131 |
CASP9 |
APAF-3; APAF3; ICE-LAP6; MCH6; PPP1R56 |
caspase 9 |
|
TCMBANKGE001132 |
BAX |
BCL2L4 |
BCL2 associated X, apoptosis regulator |
|
TCMBANKGE001135 |
SREBF1 |
SREBP1; bHLHd1 |
sterol regulatory element binding transcription factor 1 |
|
TCMBANKGE001148 |
VEGFA |
MVCD1; VEGF; VPF |
vascular endothelial growth factor A |
|
TCMBANKGE001154 |
CREB1 |
CREB; CREB-1 |
cAMP responsive element binding protein 1 |
|
TCMBANKGE001156 |
CASP3 |
CPP32; CPP32B; SCA-1 |
caspase 3 |
|
TCMBANKGE001161 |
IL2 |
IL-2; TCGF; lymphokine |
interleukin 2 |
|
TCMBANKGE001164 |
RAF1 |
CMD1NN; CRAF; NS5; Raf-1; c-Raf |
Raf-1 proto-oncogene, serine/threonine kinase |
|
TCMBANKGE001166 |
BCL2 |
Bcl-2; PPP1R50 |
BCL2 apoptosis regulator |
|
TCMBANKGE001177 |
TP53 |
BCC7; BMFS5; LFS1; P53; TRP53 |
tumor protein p53 |
|
TCMBANKGE001181 |
TGFB1 |
CED; DPD1; IBDIMDE; LAP; TGF-beta1; TGFB; TGFbeta |
transforming growth factor beta 1 |
|
TCMBANKGE001182 |
SIRT1 |
SIR2; SIR2L1; SIR2alpha |
sirtuin 1 |
|
TCMBANKGE001201 |
MAPK3 |
ERK-1; ERK1; ERT2; HS44KDAP; HUMKER1A; P44ERK1; P44MAPK; PRKM3; p44-ERK1; p44-MAPK |
mitogen-activated protein kinase 3 |
|
TCMBANKGE001203 |
MAPK1 |
ERK; ERK-2; ERK2; ERT1; MAPK2; P42MAPK; PRKM1; PRKM2; p38; p40; p41; p41mapk; p42-MAPK |
mitogen-activated protein kinase 1 |
|
TCMBANKGE001732 |
ITGAL |
CD11A; LFA-1; LFA1A |
integrin subunit alpha L |
|
TCMBANKGE001811 |
PTHLH |
BDE2; HHM; PLP; PTHR; PTHRP |
parathyroid hormone like hormone |
|
TCMBANKGE001910 |
CYP2C8 |
CPC8; CYP2C8DM; CYPIIC8; MP-12/MP-20 |
cytochrome P450 family 2 subfamily C member 8 |
|
TCMBANKGE001991 |
CCND3 |
- |
cyclin D3 |
|
TCMBANKGE002031 |
TAGLN2 |
HA1756 |
transgelin 2 |
|
TCMBANKGE002285 |
CYP3A7 |
CP37; CYPIIIA7; P-450(HFL33); P-450111A7; P450-HFLA; P450HLp2 |
cytochrome P450 family 3 subfamily A member 7 |
|
TCMBANKGE002699 |
TH |
DYT14; DYT5b; TYH |
tyrosine hydroxylase |
|
TCMBANKGE004006 |
RASD1 |
AGS1; DEXRAS1; MGC:26290 |
ras related dexamethasone induced 1 |
|
TCMBANKGE004151 |
PRL |
GHA1 |
prolactin |
|
TCMBANKGE005053 |
AQP2 |
AQP-CD; WCH-CD |
aquaporin 2 |
|
TCMBANKGE005422 |
CD59 |
16.3A5; 1F5; EJ16; EJ30; EL32; G344; HRF-20; HRF20; MAC-IP; MACIF; MEM43; MIC11; MIN1; MIN2; MIN3; MIRL; MSK21; p18-20 |
CD59 molecule (CD59 blood group) |
|
TCMBANKGE006373 |
TYW1 |
RSAFD1; TYW1A; YPL207W |
tRNA-yW synthesizing protein 1 homolog |
|
TCMBANKGE007202 |
CETP |
BPIFF; HDLCQ10 |
cholesteryl ester transfer protein |
|
TCMBANKGE007597 |
NOX3 |
GP91-3; MOX-2 |
NADPH oxidase 3 |
|
TCMBANKGE007868 |
HMGCS2 |
- |
3-hydroxy-3-methylglutaryl-CoA synthase 2 |
|
TCMBANKGE008048 |
SLC5A7 |
CHT; CHT1; CMS20; HMN7A |
solute carrier family 5 member 7 |
|
TCMBANKGE008649 |
INSIG1 |
CL6 |
insulin induced gene 1 |
|
TCMBANKGE009068 |
PRKD1 |
CHDED; PKC-MU; PKCM; PKD; PRKCM |
protein kinase D1 |
|
TCMBANKGE009256 |
SLC6A2 |
NAT1; NET; NET1; SLC6A5 |
solute carrier family 6 member 2 |
|
TCMBANKGE009304 |
FDFT1 |
DGPT; ERG9; SQS; SQSD; SS |
farnesyl-diphosphate farnesyltransferase 1 |
|
TCMBANKGE009771 |
GAP43 |
B-50; GAP-43; PP46 |
growth associated protein 43 |
|
TCMBANKGE009863 |
MTRR |
MSR; cblE |
5-methyltetrahydrofolate-homocysteine methyltransferase reductase |
|
TCMBANKGE010696 |
COQ9 |
C16orf49; COQ10D5 |
coenzyme Q9 |
|
TCMBANKGE010949 |
CENPF |
CENF; CILD31; PRO1779; STROMS; hcp-1 |
centromere protein F |
|
TCMBANKGE011031 |
CYP2C9 |
CPC9; CYP2C; CYP2C10; CYPIIC9; P450IIC9 |
cytochrome P450 family 2 subfamily C member 9 |
|
TCMBANKGE011356 |
NDOR1 |
CIAE1; NR1; bA350O14.9 |
NADPH dependent diflavin oxidoreductase 1 |
|
TCMBANKGE011543 |
HMGCS1 |
HMGCS |
3-hydroxy-3-methylglutaryl-CoA synthase 1 |
|
TCMBANKGE011668 |
RAP1A |
C21KG; G-22K; KREV-1; KREV1; RAP1; SMGP21 |
RAP1A, member of RAS oncogene family |
|
TCMBANKGE012155 |
SLC6A3 |
DAT; DAT1; PKDYS; PKDYS1 |
solute carrier family 6 member 3 |
|
TCMBANKGE012168 |
SREBF2 |
SREBP-2; SREBP2; bHLHd2 |
sterol regulatory element binding transcription factor 2 |
|
TCMBANKGE013090 |
DUOX2 |
LNOX2; NOXEF2; P138-TOX; TDH6; THOX2 |
dual oxidase 2 |
|
TCMBANKGE013277 |
GRP |
BN; GRP-10; preproGRP; proGRP |
gastrin releasing peptide |
|
TCMBANKGE013390 |
CASP2 |
CASP-2; ICH1; NEDD-2; NEDD2; PPP1R57 |
caspase 2 |
|
TCMBANKGE014099 |
CDC42 |
CDC42Hs; G25K; TKS |
cell division cycle 42 |
|
TCMBANKGE014995 |
CYP3A5 |
CP35; CYPIIIA5; P450PCN3; PCN3 |
cytochrome P450 family 3 subfamily A member 5 |
|
TCMBANKGE015054 |
DUOX1 |
LNOX1; NOXEF1; THOX1 |
dual oxidase 1 |
|
TCMBANKGE015090 |
CYP1A2 |
CP12; CYPIA2; P3-450; P450(PA) |
cytochrome P450 family 1 subfamily A member 2 |
滇ICP备16009434号-1 |
Dai SX Lab